Reuters: Regulatory News: Medifast subsidiary to pay $3.7 mln penalty for weight claims

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Medifast subsidiary to pay $3.7 mln penalty for weight claims Sep 7th 2012, 15:19 WASHINGTON, Sept 7 | Fri Sep 7, 2012 11:19am EDT WASHINGTON, Sept 7 (Reuters) - A subsidiary of Medifast Inc agreed to pay a $3.7 million civil penalty and meet new compliance requirements to settle a complaint from U.S. authorities that its claims about weight-loss products are unsubstantiated. Jason Pharmaceuticals Inc, a wholly owned Medifast subsidiary, did not admit liability, according to a consent decree filed on Friday in U.S. District Court for the District of Columbia. The company, the U.S. Justice Department and the Federal Trade Commission are parties to the consent decree.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions